CAMP FY 2016 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$351M+25.1% YoY

Gross Profit

$143M40.8% margin

Operating Income

$1M0.4% margin

Net Income

-$7M-2.0% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$18M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$408M

Total Liabilities

$244M

Stockholders' Equity

$164M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$351M	$281M	+25.1%
Gross Profit	$143M	$103M	+39.2%
Operating Income	$1M	$28M	-95.2%
Net Income	-$7M	$17M	-142.2%